Le Lézard
Classified in: Health, Science and technology
Subject: FDA

Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line


SAN DIEGO, April 19, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the United States Food and Drug Administration (FDA) has approved the company's high potency vial line to manufacture a commercial product.

"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of preparation, diligence and support from the Aji Bio-Pharma team across our whole organization. As a leading global CDMO, we are dedicated to providing high-quality drug process development and manufacturing services to biotechnology and pharmaceutical companies worldwide." said Bert Barbosa, President & COO, Ajinomoto Bio Pharma Services, US.

Aji Bio-Pharma has six fill finish lines located in San Diego, including a new line that offers a range of configurations, including prefilled syringes, cartridges and vials. The high-speed process is rated to move up to 22,000 syringes per hour through the line, with a batch capacity of over 200 thousand syringes. This multi-purpose fill line has been designed to meet FDA and EMEA commercial compliance.

About Ajinomoto Bio-Pharma Services

Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India, providing comprehensive development, cGMP API manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including high potency APIs (HPAPI), continuous flow manufacturing, oligonucleotide synthesis, biocatalysis, Corynex® protein expression technology, antibody drug conjugations (ADC) and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our client's needs. Learn more: www.AjiBio-Pharma.com

SOURCE Ajinomoto Bio-Pharma Services


These press releases may also interest you

at 15:18
Rural fiber-optic network solutions leader Conexon has introduced a new recognition program for electric cooperatives that have reached the significant milestone of fiber-to-the-home (FTTH) network completion within their service territories....

at 15:15
In today's rapidly evolving telecom landscape, companies face unprecedented challenges in effectively allocating their marketing budgets and optimizing their promotional efforts. With the proliferation of digital channels and the rise of competition,...

at 15:14
"Cities Computing on the Edge" is coming to New York City. Urban environments are constantly evolving and cities need to invest in and implement sustainable ways of living to address new urban challenges and improve the quality of life of their...

at 15:08
The Ministère de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs (MELCCFP) and the California Air Resources Board (CARB) announce that due to technical issues with the transactional Web platform, the joint...

at 15:06
Within the oil and gas industry, the rapid evolution of market demands, tightening environmental...

at 15:00
Gong, the Revenue Intelligence leader, today announced the winners of the 2024 Golden Gong Awards. The awards recognize companies that are using Gong's AI-powered platform to innovate and transform their revenue organizations, boost productivity, and...



News published on and distributed by: